We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correction |

Error in Reported Percentage in: Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma FREE

Arch Dermatol. 2012;148(12):1376. doi:10.1001/jamadermatol.2013.2284.
Text Size: A A A
Published online

Error in Reported Percentage. In the Research Letter titled “Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma” by Chang and Oro, published in the November issue of the Archives (2012;148[11]:1324-1325), an incorrect percentage was reported in the second sentence of the “Results” section. That correct percentage is 5%, and so the sentence should read as follows: “The BCCs with regrowth represented 5% of all BCCs (including laBCCs, mBCCs, and nonadvanced BCCs) observed during vismodegib treatment (12 of 152) (Table).”





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Targeted Therapy Makes Inroads in Medulloblastoma. J Natl Cancer Inst 2015;107(11):djv353.
Myths in the Diagnosis and Management of Orbital Tumors. Middle East Afr J Ophthalmol ;22(4):415-20.